GADA to Attend USP Convention Meeting
April 15, 2025 - Courtney Arumugam, GADA Officer and Chair of its Industry Stakeholder Relations Subgroup, will join hundreds of representatives across health and science at the USP Convention Meeting May 5-8 to participate in critical dialogue and discussions, elect the Board of Trustees and Council of Experts, and adopt the Resolutions that outline the impact USP will have in the next five-year cycle and beyond. Arumugam represents GADA, a Voting Member of the USP Convention, to advance the interests of the generic animal drug industry and advocate for a veterinary drug-focused body within USP.

Pharma Tariffs Are Coming, Analysts Warn
April 9, 2025 – As the industry awaits official word from the administration on how the tariffs will hit, analysts go over the possibilities with one certainty: there will be increased costs for medicines. READ MORE

FDA Reorganizes Animal Drug Evaluation Structure to Better Align Innovative Products, Generic Drugs
September 26, 2024 – The U.S. Food and Drug Administration is reorganizing the Office of New Animal Drug Evaluation (ONADE), within the Center for Veterinary Medicine (CVM) into two separate offices that will handle pre-market evaluation of originator animal products and generic drugs. The reorganization will enable ONAPE to continue to build capacity to support review of new and innovative technologies, while unprecedented growth in the generic animal drug review program over the past 8-10 years has led to standing up OGAD as an independent office, to provide for concentrated focus for the generic animal drug program and maximize the program’s effectiveness. READ MORE

CVM Announces First Annual Animal Drug User Fee Educational Conference
July 17, 2024 - On Wednesday, July 17, 2024, CVM will host a public meeting to provide education for stakeholders interested in the new animal drug approval process. Available in-person and virtually, the program will discuss the animal drug approval process and the major technical sections required for ANDA approval. Q&A sessions during which the FDA will address specific questions from the in-person and virtual audience will be done as time allows. MORE INFO

GADA Sponsors Mock BE Large Animal Study for Regulators
September 18-19, 2024 – GADA will sponsor a mock bioequivalence study in large animals as field education exercise for more than 30 FDA CVM regulatory professionals. The mock study will simulate dosing, tissues residue collection and laboratory processing on a swine study on day 1, and a cattle study simulating dosing, BE and blood processing, ending with a feedlot tour on day 2. Participation is limited and available on a first-come, first-serve basis for GADA Member representatives; log in for more details.

Animal Health Regulatory Affairs: Working Successfully with USDA and FDA: An Animal Health Conference sponsored by K-State Olathe
September 17-19, 2024 - K-State Olathe will sponsor an animal health conference focused on how the USDA and FDA each regulate various products and biologics intended for animal use. This three-day program will demonstrate how to navigate the USDA and FDA and provide updates on the EPA. Networking with subject matter experts, a professional skills course and a case study workshop round out the programming. MORE INFO

Wednesday, June 11, 2025
GADA Mid Year Member Meeting
Rockville, MD
MEMBERS ONLY - Log in for details/registration

Thursday, June 12, 2025
GADA-CVM Triannual
Rockville, MD/Virtual
MEMBERS ONLY - Log in for details/registration

Wednesday, October 22, 2025
GADA Annual Member Meeting
Rockville, MD
MEMBERS ONLY - Log in for details/registration

Thursday, October 23, 2025
GADA-CVM Triannual
Rockville, MD/Virtual
MEMBERS ONLY - Log in for details/registration